Distribution of ABO blood groups in acute leukaemias and lymphomas

Annals of Hematology - Tập 83 - Trang 584-587 - 2004
Murali K. Vadivelu1, Senthilkumar Damodaran2, John Solomon3, Annabelle Rajaseharan4
1MRC Centre for Protein Engineering, Addenbrooke’s Hospital, Cambridge, UK
2State University of New York, Buffalo, USA
3Clinical Epidemiology Unit, Madras Medical College, Chennai, India
4Directorate of Medical Education, Madras Medical College, Chennai, India

Tóm tắt

We studied the distribution of ABO blood groups in Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, acute myeloid leukaemia and acute lymphoblastic leukaemia, in children up to the age of 12 years, in a hospital-based retrospective study. Blood group data were recorded from the case records of all the patients in a tertiary care centre with the diagnosis of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, acute myeloid leukaemia and acute lymphoblastic leukaemia, during the period 1987–1997. There were 63 Hodgkin’s lymphoma, 78 non-Hodgkin’s lymphoma, 116 acute myeloid leukaemia and 522 acute lymphoblastic leukaemia patients. We assessed the distribution of ABO blood groups and the difference in the distribution from the source population. In Hodgkin’s lymphoma, there were 45.6% [95% confidence interval (CI): 6.8–84.5] more patients with B blood group. In acute lymphoblastic leukaemia, there were 14.3% (95% CI: 3.2–25.2) more patients with O blood group. In Hodgkin’s lymphoma and non-Hodgkin’s lymphoma patients, there were 56.5% (95% CI: 19.9–85.4) and 52.9% (95% CI: 18.1–82.6) less patients with A blood group, respectively. This shows that the relationship between the ABO blood groups and haematological malignancies merits further investigation in a population-based prospective study. This is the first study of its kind in any Indian population.

Tài liệu tham khảo

Altman DG (1999) Practical statistics for medical research. Chapman & Hall/CRC, London Cartwright RA, Gurney KA, Moorman AV (2002) Sex ratios and the risks of haematological malignancies. Br J Haematol 118:1071–1077 Daniels G (2002) Human blood groups. Blackwell, Oxford Das PK, Nair SC, Harris VK, Rose D, Mammen JJ, Bose YN, Sudarsanam A (2001) Distribution of ABO and Rh-D blood groups among blood donors in a tertiary care centre in South India. Trop Doct 31:47–48 Glaser SL, Hsu JL (2002) Hodgkin’s disease in Asians: incidence patterns and risk factors in population-based data. Leuk Res 26:261–269 Hoffman R, Benz EJJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (eds) (2000) Hematology: basic principles and practice. Churchill Livingstone, Philadelphia Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567–571 Jackson N, Menon BS, Zarina W, Zawawi N, Naing NN (1999) Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes. Ann Hematol 78:233–236 Levitan R, Razis DV, Diamond HD, Craver LF (1959) ABO blood groups in Hodgkin’s disease. Acta Haematol 22:12–19 Matteo ED, Barón AV, Chabay P, Porta J, Dragosky M, Preciado MV (2003) Comparison of Epstein–Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med 127:1325–1329 Mustacchi P, Schoenfeld EM, Lucia SP (1960) Survival in acute leukemia: the influence of blood groups, sex and age at onset. Ann Intern Med 52:1099–1107 Nagatsuka Y, Yamaki M, Watarai S, Yasuda T, Higashi H, Yamagata T, Ono Y (1996) The Epstein–Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen. Virus Res 43:57–68 Nagy P, Jako J, Kiss A, Tamas E, Telek B, Rak K (1981) Sex-linked difference in blood-group distribution among patients suffering from acute leukaemias. Br J Haematology 48:507–508 Shirley R, Desai RG (1965) Association of leukemia and blood groups. J Mol Genet 2:189–191 Steinberg AG (1960) The genetics of acute leukemia in children. Cancer 13:985–999 Vose JM, Chiu BCH, Cheson BD, Dancey J, Wright J (2002) Update on epidemiology and therapeutics for non-Hodgkin’s lymphoma. Hematology:241–262